|
|
| Research article summary (published 25 Jan 1975): |
Dimethyl sulfoxide therapy in severe retardation in monogoloid children.
Full Abstract
No abstract is available for this article. See 'Journal and Publication Information' further down the page for details that may assist you in locating this article in electronic or hard copy media. The 'Related articles' section also further down the page, where available, may show links to abstracts of articles covering similar topics.
Author information
Author/s: Aspillaga, M J (MJ); Morizon, G (G); Avendaņo, I (I); Sanchez, M (M); Capdeville, L (L);
Journal and publication information
Publication Type: Journal Article
Journal: Annals of the New York Academy of Sciences (Ann N Y Acad Sci), published in UNITED STATES. (Language: eng)
Reference: 1975-Jan; vol 243 (issue ) : pp 421-31
Dates: Created 1975/07/20; Completed 1975/07/20; Revised 2004/11/17;
PMID: 124151, status: MEDLINE (last retrieval date: 2/18/2009, IMS Date: )
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
Related articles
These are the highest related articles currently in the database:
- Oral dimethyl sulfoxide in mental retardation. Part 1. Preliminary behavioral and psychometric data. Part 2: Preliminary medical data.
25 Jan 1975 - Dimethyl sulfoxide therapy in nonmongoloid infantile oligophrenia.
25 Jan 1975 - 5-hydroxytryptophan (5-HTP) in Down's syndrome.
30 May 1971 - Platelet-rich plasma 5-hydroxytryptamine, urinary 5-hydroxyindoleacetic acid and tryptophan ingestion in mongols.
29 Nov 1971 - AML patients with Down syndrome have a high cure rate with AML-BFM therapy with reduced dose intensity.
30 Jul 2005 - Increased plasma and erythrocyte selenium concentrations but decreased erythrocyte glutathione peroxidase activity after selenium supplementation in children with Down syndrome.
30 Oct 1989 - Tryptophan treatment of infants with Down's syndrome.
30 Jan 1974 - Effects of nutritional supplementation on IQ and certain other variables associated with Down syndrome.
30 Aug 1983 - 5-hydroxytryptophan and pyridoxine. Their effects in young children with Down's syndrome.
30 Aug 1980
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a large map of 100+ related articles.